Central Nervous System Relapse of Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 10, 2008, Pages 1100-1107

  Oshima, Kumi ^a   Kanda, Yoshinobu ^a   Yamashita, Takuya ^b   Takahashi, Satoshi ^c   Mori, Takehiko ^d   Nakaseko, Chiaki ^e   Fujimaki, Katsumichi ^f   Yokota, Akira ^g   Fujisawa, Shin ^h   Matsushima, Takafumi ⁱ   Fujita, Hiroyuki ^j   Sakura, Tohru ^k   Okamoto, Shinichiro ^d   Maruta, Atsuo ^l   Sakamaki, Hisashi ^b  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^c THE UNIVERSITY OF TOKYO   (Japan)

^d KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f YOKOHAMA CITY UNIVERSITY   (Japan)

^g CHIBA AOBA MUNICIPAL HOSPITAL   (Japan)

^h YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

ⁱ GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j SHIZUOKA RED CROSS HOSPITAL   (Japan)

^k SAISEIKAI MAEBASHI HOSPITAL   (Japan)

^l KANAGAWA CANCER CENTER   (Japan)

more..

Author keywords

Allogeneic hematopoietic stem cell transplantation; Central nervous system; Leukemia; Relapse

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN A; METHOTREXATE; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER INCIDENCE; CANCER INVASION; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; CENTRAL NERVOUS SYSTEM NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; LEUKEMIA; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, ACUTE; LEUKEMIC INFILTRATION; MALE; MIDDLE AGED; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 51649130416     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.07.002     Document Type: Article

References (16)

1. Thompson C.B., Sanders J.E., Flournoy N., et al. The risks of central nervous system relapse and leukoencephalopathy in patients receiving marrow transplants for acute leukemia. Blood 67 (1986) 195-199
2. Ganem G., Kuentz M., Bernaudin F., et al. Central nervous system relapses after bone marrow transplantation for acute lymphoblastic leukemia in remission. Cancer 64 (1989) 1796-1804
3. Singhal S., Powles R., Treleaven J., et al. Central nervous system relapse after bone marrow transplantation for acute leukemia in first remission. Bone Marrow Transplant 17 (1996) 637-641
4. Ruutu T., Corradini P., Gratwohl A., et al. Use of intrathecal prophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the European Group for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant 35 (2005) 121-124
5. Gooley T.A., Leisenring W., Crowley J., et al. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
6. Nagatoshi Y., Kawano Y., Nagayama J., et al. Treatment of isolated central nervous system relapse in high-risk lymphoid malignancy with allogeneic bone marrow transplantation and extended intrathecal therapy. Br J Haematol 125 (2004) 766-768
7. Potenza L., Luppi M., Riva G., et al. Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: case report and review of the literature. Am J Hematol 81 (2006) 45-50
8. Ostronoff M., Domingues M.C., Ostronoff F., et al. Reduced intensity conditioning allogeneic bone marrow transplantation following central nervous system (CNS) relapse of acute promyelocytic leukemia: evidence for a graft-versus-leukemia effect in the CNS. Am J Hematol 81 (2006) 387-388
9. Au W.Y., Lie A.K., Liang R., et al. Isolated extramedullary relapse of acute lymphoblastic leukaemia after allogeneic bone marrow transplantation. Bone Marrow Transplant 24 (1999) 1137-1140
10. Seo S., Kami M., Honda H., et al. Extramedullary relapse in the so-called "sanctuary" sites for chemotherapy after donor lymphocyte infusion. Bone Marrow Transplant 25 (2000) 226-227
11. Salutari P., Sica S., Micciulli G., et al. Extramedullary relapse after allogeneic bone marrow transplantation plus buffy-coat in two high risk patients. Haematologica 81 (1996) 182-185
12. Wilson D.B., Michalski J.M., Grossman W.J., et al. Isolated CNS relapse following stem cell transplantation for juvenile myelomonocytic leukemia. J Pediatr Hematol Oncol 25 (2003) 910-913
13. Bosi A., Laszlo D., Labopin M., et al. Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow Transplantation. J Clin Oncol 19 (2001) 3675-3684
14. Breems D.A., Van Putten W.L., Huijgens P.C., et al. Prognostic index for adult patients with acute myeloid leukemia in first relapse. J Clin Oncol 23 (2005) 1969-1978
15. Johnston D.L., Alonzo T.A., Gerbing R.B., et al. Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia. J Clin Oncol 23 (2005) 9172-9178
16. Sancho J.M., Ribera J.M., Oriol A., et al. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis. Cancer 106 (2006) 2540-2546